A STUDY TO INVESTIGATE THE PREVALENCE OF METABOLIC AND METABOLIC LIKE SYNDROME IN STABLE COPD PATIENTS

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is associated with several extrapulmonary systemic manifestations including metabolic and metabolic like syndrome. The objective of study was to assess prevalence of metabolic like syndrome among COPD patients. METHODS: This study was conducted from April 2017 to March 2018. Total 67 COPD patients were classied according to GOLD guideline. International Diabetes Federation (IDF) guideline was used for metabolic syndrome(MetS). RESULTS: Prevalence of MetS was 29.85%, highest (47.06%) in GOLD stage-II. If central obesity was excluded than prevalence of metabolic like syndrome was 55.27%, highest(70%) in stage-IV . CONCLUSIONS: MetS is missed in advance stages of COPD due to absence of central obesity. Therefore “Metabolic Like Syndrome” should be coined in COPD where waist circumference is not an included.